Taking everything into account, PGNY scores 7 out of 10 in our fundamental rating. PGNY was compared to 102 industry peers in the Health Care Providers & Services industry. Both the health and profitability get an excellent rating, making PGNY a very profitable company, without any liquidiy or solvency issues. PGNY is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make PGNY suitable for growth and quality investing!
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROIC | 11.24% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 8.52 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.05 | ||
| Fwd PE | 24.06 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 11.52 | ||
| EV/EBITDA | 18.19 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:PGNY (12/26/2025, 2:01:09 PM)
25.8625
+0.35 (+1.38%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 41.05 | ||
| Fwd PE | 24.06 | ||
| P/S | 1.76 | ||
| P/FCF | 11.52 | ||
| P/OCF | 10.71 | ||
| P/B | 3.98 | ||
| P/tB | 4.18 | ||
| EV/EBITDA | 18.19 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.11% | ||
| ROE | 10.1% | ||
| ROCE | 14.68% | ||
| ROIC | 11.24% | ||
| ROICexc | 27.43% | ||
| ROICexgc | 30.82% | ||
| OM | 6.77% | ||
| PM (TTM) | 4.46% | ||
| GM | 22.94% | ||
| FCFM | 15.25% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 330.21% | ||
| Cap/Sales | 1.16% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 230.54% | ||
| Profit Quality | 342.01% | ||
| Current Ratio | 2.96 | ||
| Quick Ratio | 2.96 | ||
| Altman-Z | 8.52 |
ChartMill assigns a fundamental rating of 7 / 10 to PGNY.
ChartMill assigns a valuation rating of 5 / 10 to PROGYNY INC (PGNY). This can be considered as Fairly Valued.
PROGYNY INC (PGNY) has a profitability rating of 7 / 10.
The Price/Earnings (PE) ratio for PROGYNY INC (PGNY) is 41.05 and the Price/Book (PB) ratio is 3.98.
The Earnings per Share (EPS) of PROGYNY INC (PGNY) is expected to grow by 38.33% in the next year.